BX
Baudax Bio, Inc.
BXRXQ · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $4.36K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/S 0.00x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 452.33%
Net margin 4,633.18%
Op. margin 4,476.99%
Quality
59 /100
Average ROIC 974.83%
ROA 586.08%
Asset turnover 0.13x
Debt
70 /100
Low Current ratio 0.30x
Net debt/EBITDA -0.06x
Debt/Equity N/A
Stability
14 /100
Unstable Beta 9.17x
EPS volatility 55.97%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BXRXQ
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Gerri Henwood
Employees
9
Headquarters
Malvern
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report